Post on 13-Apr-2017
1
Partnerships andBusiness Development
in Asia
2
Canadian biotechnology company developing biological products to improve animal health and increase animal production performance. • Products distributed Worldwide:
Coliprotec®
• Pipeline of three additional technologies
3
Prepare for a Tsunami of Change
4
The Wave of Global Hunger
Credit to Jeff Simmons, CEO of Elanco
5
Daily Talk in the News
….Since the resistance was found in humans in
relatively few cases – when compared to animals,
that is – it looks probable that this type of
resistance originated in animals and was
transferred to humans, explained the Prof
Jianzhong Shen, one of the authors of the
research and attached to the Beijing
Advanced Innovation Center for Food
Nutrition and Animal Health at the China
Agricultural University.
Tues., Jan. 5, 2016The alarming drug-resistance gene MCR-1 that was first detected in China in November has been found in meat sold in Ontario in 2010, the Star has learned. The gene grants bacteria like E. coli resistance to colistin, a powerful antibiotic of last resort.
6
March 4, 2015McDonald’s U.S. restaurants will gradually stop buying chicken raised with antibiotics vital to fighting human infections, the most aggressive step by a major food company to force chicken producers to change practices in the fight against dangerous “superbugs.” (Shannon Stapleton/Reuters)
October 4, 2016
A new federal policy aimed at reducing the unnecessary use of
antibiotics in agriculture may not be as effective as officials
intended — at least in the near-term — in addressing the
alarming rise in drug resistance, a new report suggests.
Beginning Jan. 1, the Food and Drug Administration will impose a
voluntary ban on the use of key antibiotics in healthy animals to
promote growth, a practice that is contributing to the spread of
so-called superbugs.While the policy is voluntary, the makers of antibiotics for
animals have agreed to comply, which means that starting next
year food animal producers will no longer be able to simply buy
these antibiotics at their supply stores. Veterinarians will need to
oversee their use.
Daily Talk in the News
7
Strike the right balance in the Animal Health Industry
Economic impact studies (ex) KPMG
Resistance to antibiotics because
of over use
Ban the use of antibiotics
A better way to feed the planet
9
JV with Asian Partner
10
World Pig Production
11
World Pig Production
All other countries... and ChinaUSAGermanyVietnamSpainBrazilRussiaFrancePhilippinesPolandCanadaDenmarkOthers
Sichuan HunanHenanShandongHubeiGuangdongGuanxiHebeiJiangxiYunnanJiangsuAnhuiLiaoningOthers
12
The Situation in China
• Strong growth in production• Increasing industrialization• Food safety is becoming a priority• Need for performance• Once the decision is taken to ensure
sustainable food production, very efficient and fast execution will prevail
13
Rapid, cost efficient and rewarding
Our Business Model
* Contract research organization** Contract manufacturing organization
Scouting for new technologies
Identification of a promising new technology
Proof of concept
Research by CRO* and CMO**
Prototype
Scale-up
Commercial product
Registration process
Registration
Commercializationby distributor
14
Corporate Structure
15
Prevtec’s first patented group of products on the market A family of three vaccines for the swine industry
- Post weaning diarrhea in swine F4-F18- Oedema disease- Performance in production
An efficient alternative to antibiotics
Coliprotec®
16
Our Pipeline of Technologies
• Feed Additive for Swineo Replacing ATB in animal food
• Streptococcus Suiso Multisystemic disease in swine
• Avian E. coli vaccine o Respiratory disease
• Food safety antibodieso For cattle
17
AsianJV
Prevtec Microbia HKLimited
(Hong Kong)
•Technological Transfer•Intellectual Property•Scientific Expertise•Regulatory Process•Coliprotec® Products•Technologies
•Investment $$•Geographic Market Experience & Network•Asian Regulatory Process•Distribution
ASIAN PARTNER
18
The Prevtec Advantage
Proven ability to develop and register vaccines √
Proven ability to generate near term cash in countries with current vaccine regulatory approvals √
Proven team with demonstrated ability to partner with major companies to finance, develop, manufacture and commercialize
√
Potential new products of non-antibiotic, vaccine-related technologies to prevent and treat food animal diseases
√
Poised to become the non-antibiotic, anti-infective "go to" company √
19
Partnering up with the Best
• Animal Pharm Award 2015 Best New Product – food animals
• GOLD LEAF AWARD 2015 - BIOTECanada - Prevtec awarded Emerging Company of the Year
• ADRIQ Innovative Product Award 2015 - Prevtec awarded for its Innovative Product, Coliprotec® F4, bringing a discovery to commercialization in key markets
• ADRIQ 2008 “Coup de coeur” and finalist for its innovation technology
20
Thank You